MARC Record from marc_columbia

LEADER: 06134fam a2200529 a 4500
001 4062754
005 20221027030147.0
008 000203t20002000nyua b 101 0 eng c
010 $a 00022405
020 $a030646375X
035 $a(OCoLC)43442031
035 $a(OCoLC)ocm43442031
035 $a(DNLM)100928622
035 $9AQP8928HS
035 $a(NNC)4062754
035 $a4062754
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
042 $apcc
050 00 $aQP106.6$b.A195 2000
060 10 $aW1$bAD559 v. 476 2000
060 10 $aWG 500$bA5843 2000
082 00 $a612.1/3$221
245 00 $aAngiogenesis :$bfrom the molecular to integrative pharmacology /$cedited by Michael E. Maragoudakis.
260 $aNew York :$bKluwer Academic/Plenum,$c[2000], ©2000.
300 $ax, 382 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in experimental medicine and biology ;$vv. 476
500 $a"Proceedings of the 5th Biannual International Meeting on Angiogenesis: From the Molecular to Integrative Pharmacology, held July 1-7, 1999, in Crete, Greece"--T.p. verso.
504 $aIncludes bibliographical references and index.
505 00 $tIntroduction Comments /$rM. E. Maragoudakis --$tAngiogenic Factors and their Receptors.$tExamining New Models for the Study of Autocrine and Paracrine Mechanisms of Angiogenesis through FGF[subscript 2]-Transfected Endothelial and Tumour Cells /$rM. Presta, M. Rusnati and P. Dell'Era /$r[et al.].$tTie-1 Receptor Tyrosine Kinase Endodomain Interaction with SHP2: Potential Signalling Mechanisms and Roles in Angiogenesis /$rM. Marron, D. Hughes and M. McCarthy /$r[et al.].$tOn the Mechanism(s) of Thrombin Induced Angiogenesis /$rM. E. Maragoudakis and N. E. Tsopanoglou.$tEndothelial Receptor Tyrosine Kinases in Involved Blood Vessel Development and Tumor Angiogenesis /$rG. Breier.$tOntogeny of the Endothelial System in the Avian Model /$rL. Pardanaud and F. Dieterlen-Lievre --$tRegulation of Angiogenesis and Transduction Mechanisms Involved.$tThe Role of Pericytes in Controlling Angiogenesis In Vivo /$rS. Egginton, A.-L. Zhou and M. D. Brown /$r[et al.].
505 80 $tInsights into the Vasodilation of Rat Retinal Vessels Evoked by Vascular Endothelial Growth Factor[subscript 121] (VEGF[subscript 121]) /$rH. M. Hassessian.$tSignal Transduction and Transcriptional Regulation of Angiogenesis /$rY. Sato, M. Abe and K. Tanaka /$r[et al.].$tDifferential Contribution of Bradykinin Receptors in Angiogenesis /$rL. Morbidelli, A. Parenti and S. Donnini /$r[et al.].$tSensitivity of Different Vascular Beds in the Eye to Neovascularization and Blood-Retinal Barrier Breakdown in VEGF Transgenic Mice /$rS. A. Vinores, N. L. Derevjanik and M. A. Vinores /$r[et al.].$tRevascularization of Ischemic Tissues with SIKVAV and Neuropeptide Y (NPY) /$rD. S. Grant and Z. Zukowska.$tCellular Effects and Signalling Pathways Activated by the Anti-Coagulant Factor, Protein S, in Vascular Cells /$rC. Kanthou and O. Benzakour --$tRole of Extracellular Matrix and Adhesion Molecules in Angiogenesis.
505 80 $tTargeting Integrins a[subscript v]b[subscript 3] and a[subscript v]b[subscript 5] for Blocking Tumor-Induced-Angiogenesis /$rC. Kumar, L. Armstrong and Z. Yin /$r[et al.].$tSuppression of Human Microvascular Endothelial Cell Invasion and Morphogenesis with Synthetic Matrixin Inhibitors /$rM.-C. Jia, M. A. Schwartz and Q. X. Sang --$tInhibitors of Angiogenesis and their Mechanisms of Action.$tTunicamycin Inhibits Capillary Endothelial Cell Proliferation by Inducing Apoptosis /$rJ. A. Martinez, I. Torres-Negron and L. A. Amigo /$r[et al.].$tThe Characterization of Angiogenesis Inhibitor from Shark Cartilage /$rJ. H. Liang and K. P. Wong.$tQuantitative Assays for the Chick Chorioallantoic Membrane /$rD. W. Thompson and A. Reid --$tAngiogenesis and Malignant Transformation.$tMYCN Oncogene and Angiogenesis: Down-Regulation of Endothelial Growth Inhibitors in Human Neuroblastoma Cell /$rE. Hatzi, S. Breit and A. Zoephel /$r[et al.].
505 80 $tFrom Hyperplasia to Neoplasia and Invasion: Angiogenesis in the Colorectal Adenoma-Carcinoma Model /$rL. Kaklamanis, S. Kakolyris and M. Koukourakis /$r[et al.].$tTumor Angiogenesis, Macrophages, and Cytokines /$rH. Bando and M. Toi.$tMicrovessel Density, Thymidine Phosphorylase Expression, and Resistance of Head and Neck Cancer to Chemo-Radiotherapy /$rM. Koukourakis.$tDifferential Expression of Angiogenic and of Vascular Survival Factors in Non-Small Cell Lung Cancer (NSCLC) /$rA. Gatromanolaki.$tThymidine Phosphorylase Activity in Normal, Hyperplastic and Neoplastic Endometrium-Correlation with Intratumoral Angiogenesis /$rE. Sivridis --$tPreclinical Developments of Angiogenesis Inhibitors.$tInhibition of VEGF Signal Transduction /$rS. Wedge and D. Ogilvie.$tCombretastatins: Novel Vascular Targeting Drugs for Improving Anti-Cancer Therapy /$rM. Horsman, R. Murata and T. Breidahl /$r[et al.] --$tClinical Applications.$tTherapeutic Angiogenesis for Ischemic Heart Disease /$rA. Helisch and J. A. Ware.
650 0 $aNeovascularization$vCongresses.
650 0 $aNeovascularization inhibitors$vCongresses.
650 0 $aGrowth factors$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008118450
650 12 $aAngiogenesis Inducing Agents$xphysiology.
650 22 $aCell Transformation, Neoplastic.$0https://id.nlm.nih.gov/mesh/D002471
650 22 $aNeovascularization, Pathologic.$0https://id.nlm.nih.gov/mesh/D009389
650 22 $aNeovascularization, Physiologic$xdrug effects.$0https://id.nlm.nih.gov/mesh/D018919Q000187
650 22 $aSignal Transduction.$0https://id.nlm.nih.gov/mesh/D015398
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aMaragoudakis, Michael E.$0http://id.loc.gov/authorities/names/n92800685
711 2 $aInternational Meeting on Angiogenesis$n(5th :$d1999 :$cCrete, Greece)
830 0 $aAdvances in experimental medicine and biology ;$vv. 476.$0http://id.loc.gov/authorities/names/n42001229
852 00 $boff,hsl$hQP106.6$i.A195 2000